BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1419086)

  • 1. [Depression in Parkinson's disease and its relation to the cognitive and motor manifestations].
    Gil Saladié D; Delgado González M; Oliveras Ley C; Peña Casanova J; Barraquer Bordas L
    Neurologia; 1992; 7(7):176-80. PubMed ID: 1419086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depression is associated with impairment of ADL, not motor function in Parkinson disease.
    Holroyd S; Currie LJ; Wooten GF
    Neurology; 2005 Jun; 64(12):2134-5. PubMed ID: 15985588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cognitive deterioration in Parkinson's disease].
    Vilert Barnet J; Jarne Esparcia A; Aguilar Barbera M
    Arch Neurobiol (Madr); 1991; 54(6):311-7. PubMed ID: 1811462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anxiety and depression: main determinants of health-related quality of life in Brazilian patients with Parkinson's disease.
    Carod-Artal FJ; Ziomkowski S; Mourão Mesquita H; Martínez-Martin P
    Parkinsonism Relat Disord; 2008; 14(2):102-8. PubMed ID: 17719828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive performance in nondemented nonpsychotic Parkinson disease patients with or without a history of depression prior to the onset of motor symptoms.
    Klepac N; Hajnsek S; Trkulja V
    J Geriatr Psychiatry Neurol; 2010 Mar; 23(1):15-26. PubMed ID: 19996416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease.
    Weintraub D; Moberg PJ; Duda JE; Katz IR; Stern MB
    J Am Geriatr Soc; 2004 May; 52(5):784-8. PubMed ID: 15086662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual dysfunction in Parkinson disease without dementia.
    Uc EY; Rizzo M; Anderson SW; Qian S; Rodnitzky RL; Dawson JD
    Neurology; 2005 Dec; 65(12):1907-13. PubMed ID: 16282276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.
    Aarsland D; Brønnick K; Larsen JP; Tysnes OB; Alves G;
    Neurology; 2009 Mar; 72(13):1121-6. PubMed ID: 19020293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Improvements in motor and non-motor symptoms in parkinson patients under ropinirole therapy].
    Buchwald B; Angersbach D; Jost WH
    Fortschr Neurol Psychiatr; 2007 Apr; 75(4):236-41. PubMed ID: 17427044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depression impairs executive functioning in Parkinson disease patients with low educational level.
    Kummer A; Harsányi E; Dias FM; Cardoso F; Caramelli P; Teixeira AL
    Cogn Behav Neurol; 2009 Sep; 22(3):167-72. PubMed ID: 19741326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of bilateral subthalamic nucleus deep brain stimulation (STN DBS) on cognition in Parkinson disease.
    Heo JH; Lee KM; Paek SH; Kim MJ; Lee JY; Kim JY; Cho SY; Lim YH; Kim MR; Jeong SY; Jeon BS
    J Neurol Sci; 2008 Oct; 273(1-2):19-24. PubMed ID: 18640690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and clinical correlates of apathy in Parkinson's disease: a community-based study.
    Pedersen KF; Larsen JP; Alves G; Aarsland D
    Parkinsonism Relat Disord; 2009 May; 15(4):295-9. PubMed ID: 18801696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "DASH" symptoms in patients with Parkinson's disease: red flags for early cognitive decline.
    Naismith SL; Lewis SJ
    J Clin Neurosci; 2011 Mar; 18(3):352-5. PubMed ID: 21237647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral, neuropsychiatric and cognitive disorders in Parkinson's disease patients with and without motor complications.
    Solla P; Cannas A; Floris GL; Orofino G; Costantino E; Boi A; Serra C; Marrosu MG; Marrosu F
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1009-13. PubMed ID: 21324349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The independent influence of apathy and depression on cognitive functioning in Parkinson's disease.
    Butterfield LC; Cimino CR; Oelke LE; Hauser RA; Sanchez-Ramos J
    Neuropsychology; 2010 Nov; 24(6):721-30. PubMed ID: 20853956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depression predicts the pattern of cognitive impairment in early Parkinson's disease.
    Stefanova E; Potrebic A; Ziropadja L; Maric J; Ribaric I; Kostic VS
    J Neurol Sci; 2006 Oct; 248(1-2):131-7. PubMed ID: 16780884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-perceived involvement and satisfaction in Parkinson's disease: effect on therapy decisions and quality of life.
    Grosset KA; Grosset DG
    Mov Disord; 2005 May; 20(5):616-9. PubMed ID: 15719417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Management of psychiatric complications of Parkinson's disease].
    Fénelon G
    Rev Prat; 2005 Apr; 55(7):733-9. PubMed ID: 15966416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Psychoses in patients with Parkinson's disease; their frequency, phenomenology, and clinical correlates].
    Kashihara K; Ohno M; Katsu Y
    Rinsho Shinkeigaku; 2005 Jan; 45(1):1-5. PubMed ID: 15714992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for cognitive deficits in Parkinson's disease with the Parkinson neuropsychometric dementia assessment (PANDA) instrument.
    Kalbe E; Calabrese P; Kohn N; Hilker R; Riedel O; Wittchen HU; Dodel R; Otto J; Ebersbach G; Kessler J
    Parkinsonism Relat Disord; 2008; 14(2):93-101. PubMed ID: 17707678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.